Non-Alcoholic Fatty Liver Disease (NAFLD) is currently the most common cause of chronic
liver disease worldwide, and its prevalence is increasing globally. NAFLD is a multifaceted …

Introduction and objectives Fatty liver disease is an important public health problem. Early
diagnosis is critical to lower its rate of progression to irreversible/terminal stages. This study …

In the United States, non-alcoholic fatty liver disease (NAFLD) is the most common liver
disease and associated with higher mortality according to data from earlier National Health …

METHODS: This study included 11,593,409 subjects from the National Health Information
Database of the Republic of Korea entered in 2010 and followed up until 2016. NAFLD was …

Fatty liver disease is the most common liver disease in the world. Its connection with the gut
microbiome has been known for at least 80 y, but this association remains mostly unstudied …

Background Possible associations of chronic kidney disease (CKD) with fatty liver (FL) and
nonalcoholic fatty liver disease (NAFLD) have recently been focused on. Metabolic …

The gut microbiome has shown promise as a predictive biomarker for various diseases.
However, the potential of gut microbiota for prospective risk prediction of liver disease has …

Background There is an ongoing debate on whether fructose plays a role in the
development of nonalcoholic fatty liver disease. Objectives The aim of this study was to …

Background Nonalcoholic fatty liver disease (NAFLD) is a rising global disease associated
with clinical and economic burdens. Objectives We aimed to quantify NAFLD prevalence …

Background Nonalcoholic fatty liver disease is common and is associated with rising
morbidity and mortality in the UK. Cardiovascular disease is the main cause of death in …